Conclusions: Prescription opioid-dependent patients with a co-occurring psychiatric disorder had a better response to buprenorphine-naloxone treatment despite demonstrating greater impairment at baseline. Additional research is needed to determine the mechanism of this finding and to adapt treatments to address this population.
PMID: 24219166 [PubMed – as supplied by publisher] (Source: The American Journal of Drug and Alcohol Abuse)